Loading…
Based on limited metadata, this warning letter was issued to Project 1600 Inc., a drug manufacturer, on June 18, 2020. Without access to the full letter text or subject line, the specific nature of the violations cannot be determined from the available information. The letter falls under FDA drug product regulation, though the specific issuing office is not identified in the metadata provided.